Blair William & Co. IL Has $198.48 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Blair William & Co. IL boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 389,740 shares of the healthcare conglomerate’s stock after buying an additional 6,912 shares during the period. Blair William & Co. IL’s holdings in UnitedHealth Group were worth $198,479,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Macroview Investment Management LLC raised its position in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $31,000. Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth $31,000. Finally, Signature Resources Capital Management LLC boosted its stake in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on UNH shares. TD Cowen boosted their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Royal Bank of Canada raised their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Monday. Barclays upped their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, HSBC upped their target price on shares of UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $614.17.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of UNH opened at $577.89 on Wednesday. The stock has a market cap of $531.88 billion, a P/E ratio of 35.32, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The stock’s 50-day moving average price is $572.79 and its two-hundred day moving average price is $519.00. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the firm earned $6.14 earnings per share. The business’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.